Akerman Inaugurates Japan Sector Team with Key Hire from Orrick

U.S. law firm Akerman has inaugurated a dedicated Japan sector team aiming to serve Japanese businesses with international operations. This step was facilitated, in part, through the recruitment of corporate M&A lawyer Hiroshi Sarumida, previously the U.S. chair of Orrick, Herrington & Sutcliffe’s Japan transactional practice. Sarumida will now serve as a partner at Akerman….

Read More

California Judge Approves $725M Settlement in Facebook Privacy Case Over Cambridge Analytica Scandal

In a significant privacy case, counsel representing a class of over 200 million Facebook users have secured a substantial victory with a $725 million deal. Final approval for this settlement, stemming from the notorious Cambridge Analytica data harvesting scandal, was granted by a California federal judge. The financial breakdown of the settlement sees nearly $181…

Read More

DOJ’s New M&A Safe Harbor Policy: Implications and Deadlines for Acquiring Companies

The Department of Justice (DOJ) has recently implemented a novel Mergers and Acquisitions (M&A) Safe Harbor Policy, which has clear-cut implications for both acquiring and acquired businesses in the M&A ecosystems. For acquiring companies, this policy essentially enforces a six-month window from the date of closing within which they are expected to disclose misconduct discovered…

Read More

Delaware Chancery Court Rulings: High-Stakes Decisions Impact Industry Titans and Investors

Recent developments in Delaware’s Chancery Court have sparked interest in the legal professional community, as high-profile figures and corporations battled it out in the courthouse. Notably, former executives of social media giant Twitter have successfully recouped their legal expenses. In another significant ruling, Takeda Pharmaceuticals, one of the leading pharmaceutical corporations, found itself on the…

Read More

OTC Decongestant Efficacy Debated Amid Growing Class-Action Litigation Against Pharma Giants

The issue of efficacy of over-the-counter decongestants has once again made headlines as class-action lawsuits continue piling up against leading pharmaceutical companies. The contention at the heart of these lawsuits highlights an alleged ineffectiveness of certain pharmaceutical products, which has provoked a wide array of concerns among consumers and professionals alike in the health industry….

Read More

Purdue Pharma vs. Accord Healthcare: The Impact on Pharmaceutical Patent Battles and Industry Precedent

In the world of pharmaceutical law, new cases with intriguing developments and possible generational ramifications pop up quite frequently. One such instance is the ongoing Purdue Pharma L.P. v. Accord Healthcare Inc., a case that draws attention to the highly sensitive matter of patents related to OxyContin® (oxycodone HCl). Here is a closer look at…

Read More

Ranbaxy Requests Lipitor Class Certification Hearing Postponement Due to Attorney Trapped in War Zone

Ranbaxy Laboratories Ltd., an India-based pharmaceutical company, has requested a class certification hearing related to their cholesterol medication, Lipitor, to be postponed. The request submitted to a New Jersey federal court cites a unique predicament – one of their attorneys, who has yet to be identified, is said to be trapped in a war zone…

Read More

JPML Consolidates Actions in Russian Cybergang’s Exploitation of MOVEit Software Vulnerability

On October 4, 2023, a significant development took place in the legal sphere relating to cybercrime. The Joint Panel on Multidistrict Litigation (JPML) made a notable move: it issued a Transfer Order that consolidated certain actions stemming from an incident back in May 2023 where a Russian cybergang exploited a vulnerability in Progress Software’s MOVEit…

Read More

EPA Issues Final Rule on PFAS Reporting: Impact on Manufacturing and Legal Landscape

The U.S. Environmental Protection Agency (EPA) has recently issued a final rule that mandates the reporting of prior manufacturing of per- and polyfluoroalkyl substances (PFAS). The rule falls under the jurisdiction of the Toxic Substances Control Act (TSCA) and applies to both domestically produced and imported goods. Integrating this requirement into the existing legal framework…

Read More

Special Master in Opioid Litigation Retained Despite Email Incident, Citing Judicial Deliberative Privilege

In a recent development concerning the opioid multidistrict litigation, U.S District Judge Dan Polster ruled that David Cohen, the special master assigned to the litigation since 2018, would not be disqualified from the case. The decision comes after Cohen inadvertently sent an email intended for himself to the lawyers involved in the case, prompting a…

Read More

Litigation Finance’s Expanding Role in IP Ecosystem: Key Insights from LF Dealmakers Forum

The recent LF Dealmakers forum, a major event for litigation finance professionals, provided some valuable takeaways for IP lawyers and their clients, further cementing litigation funding’s relevance in today’s IP litigation field. The forum tackled important subjects and opened discussions on an array of topics crucial to IP practitioners. The significance of the rapidly growing…

Read More

Ultima Services Corporation Challenges 8(a) Contract Awards in Ongoing Federal Lawsuit

On Friday, October 6, 2023, in a significant legal development, Ultima Services Corporation, an influential participant in the administrative and technical support industry, filed a reply brief in the case, Ultima Services Corp. v. U.S. Dept. of Agriculture, et. al., Case No. 2:20-cv-00041. The reply brief continues to argue for an injunction against the award…

Read More

Proposed FAR Rules Set to Impact Cybersecurity Responsibilities for Government Contractors

The Federal Acquisition Regulatory (FAR) Council released two notable proposals on October 3, 2023, which are likely to usher in significant changes to the duties of government contractors in terms of cybersecurity. The implications of these proposed changes are potentially far-reaching, and it is crucial for legal professionals dealing with government contracts to acquaint themselves…

Read More

Decoding Triggers of Litigation Hold for E-Discovery in the Digital Age

In today’s increasingly digital world, understanding the intricacies of e-discovery becomes more important than ever for legal professionals. This extends to discerning what triggers litigation hold, a process essential to the proper preservation of evidence in legal proceedings. As detailed in a recent publication by the Association of Certified E-Discovery, the journey to demystify the…

Read More

Navigating Complex Legal Challenges: Healthcare Litigation, Compliance, and Investigations Forum 2023

In an increasingly complex legal landscape, the Healthcare Litigation, Compliance and Investigations Forum presents a vital opportunity for professionals navigating the healthcare arena. Organized by leading international law firm McDermott Will & Emery, this year’s event is scheduled for November 1st, 2023, in Chicago, Illinois, and will be conducted in a hybrid format. JD Supra…

Read More